| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.65B | 11.30B | 11.21B | 10.21B | 8.63B | 6.15B |
| Gross Profit | 4.55B | 4.39B | 4.38B | 4.04B | 3.37B | 1.95B |
| EBITDA | 1.88B | 1.85B | 1.94B | 1.88B | 1.58B | 534.59M |
| Net Income | 1.20B | 1.20B | 1.29B | 1.24B | 985.84M | 175.84M |
Balance Sheet | ||||||
| Total Assets | 6.63B | 6.00B | 5.71B | 5.37B | 4.76B | 5.09B |
| Cash, Cash Equivalents and Short-Term Investments | 242.75M | 703.20M | 766.59M | 737.88M | 431.56M | 1.05B |
| Total Debt | 2.29B | 1.92B | 1.91B | 1.90B | 1.85B | 1.90B |
| Total Liabilities | 4.03B | 3.51B | 3.43B | 3.41B | 3.23B | 3.09B |
| Stockholders Equity | 2.60B | 2.49B | 2.28B | 1.96B | 1.54B | 2.00B |
Cash Flow | ||||||
| Free Cash Flow | 952.12M | 964.15M | 1.04B | 1.17B | 887.08M | 658.49M |
| Operating Cash Flow | 1.30B | 1.34B | 1.48B | 1.48B | 1.06B | 810.36M |
| Investing Cash Flow | -751.61M | -383.09M | -441.43M | -314.58M | -176.48M | -48.75M |
| Financing Cash Flow | -715.88M | -1.02B | -1.01B | -861.01M | -1.50B | -107.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $23.73B | 20.29 | 48.52% | ― | 2.94% | 4.57% | |
71 Outperform | $1.38B | 7.50 | 27.54% | ― | -0.38% | 35.78% | |
70 Outperform | $37.90B | 18.25 | 42.43% | 1.40% | 4.89% | 17.30% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | $4.54B | 6.54 | ― | 3.49% | -0.18% | -18.95% | |
54 Neutral | $13.91B | 94.61 | 34.48% | ― | 9.04% | -56.79% | |
53 Neutral | $6.31B | 40.88 | ― | ― | 1.98% | -20.98% |
On October 16, 2025, Ulta Beauty announced the appointment of Christopher DelOrefice as Chief Financial Officer, effective December 5, 2025. DelOrefice, who has extensive experience in financial leadership roles at Becton Dickinson & Company and Johnson & Johnson, will replace interim CFO Chris Lialios. This strategic appointment is expected to bolster Ulta Beauty’s financial operations and support its long-term growth strategy. DelOrefice’s compensation package includes a base salary, cash incentives, and equity awards, reflecting the company’s commitment to attracting top talent to drive its financial performance and shareholder value.
The most recent analyst rating on (ULTA) stock is a Sell with a $450.00 price target. To see the full list of analyst forecasts on Ulta Beauty stock, see the ULTA Stock Forecast page.
Ulta Beauty’s recent earnings call painted a picture of robust growth tempered by strategic challenges. The company reported significant sales growth and expansion in its loyalty program, alongside successful international ventures. However, it also faced a decline in operating margin and increased SG&A expenses due to strategic investments.
Ulta Beauty, Inc. is the largest specialty beauty retailer in the United States, offering a wide range of cosmetics, skincare, haircare, fragrance, and salon services. The company is known for its expansive product assortment and personalized shopping experiences across its physical stores and digital platforms.
On August 20, 2025, Ulta Beauty‘s Board of Directors expanded from ten to twelve members, appointing Martin Brok and Stephenie Landry as independent directors, effective September 1, 2025. These appointments, announced on August 21, 2025, bring significant expertise to Ulta Beauty, with Brok’s extensive experience in global consumer brands and retail innovation, and Landry’s background in consumer technology and strategic transformation. This strategic move is expected to enhance Ulta Beauty’s growth trajectory and strengthen its market position, as the company continues to diversify its board with 67% women and 33% racially diverse members.
The most recent analyst rating on (ULTA) stock is a Buy with a $640.00 price target. To see the full list of analyst forecasts on Ulta Beauty stock, see the ULTA Stock Forecast page.
On August 14, 2025, Ulta Beauty and Target Corporation announced their decision not to renew the Ulta Beauty at Target shop-in-shop partnership when the current agreement ends in August 2026. This decision is not expected to significantly impact Ulta Beauty’s fiscal 2025 financial results or long-term financial targets. The partnership, which began in 2021, has been successful in expanding access to prestige beauty and offering convenience through linked rewards programs. Both companies remain committed to providing a seamless shopping experience until the partnership concludes, while Ulta Beauty continues to focus on its growth plans, including the launch of Ulta Beauty Marketplace.
The most recent analyst rating on (ULTA) stock is a Hold with a $395.00 price target. To see the full list of analyst forecasts on Ulta Beauty stock, see the ULTA Stock Forecast page.